about
Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study.Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington's disease: A proposal to chemists!Exploring pyrazolo[3,4-d]pyrimidine phosphodiesterase 1 (PDE1) inhibitors: a predictive approach combining comparative validated multiple molecular modelling techniques.Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies.Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery.Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors.Shedding light on designing potential meprin β inhibitors through ligand-based robust validated computational approaches: A proposal to chemists!Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.An integrated QSAR modeling approach to explore the structure-property and selectivity relationships of N-benzoyl-L-biphenylalanines as integrin antagonists.Homoisoflavonoids as potential antiangiogenic agents for retinal neovascularization.Insight into the structural requirements of pyrimidine-based phosphodiesterase 10A (PDE10A) inhibitors by multiple validated 3D QSAR approaches.An Integrated Multi-QSAR Modeling Approach for Designing Knoevenagel- Type Indoles with Enhancing Cytotoxic Profiles.Pharmacoinformatics study of Piperolactam A from Piper betle root as new lead for non steroidal anti fertility drug development.Structural exploration of hydroxyethylamines as HIV-1 protease inhibitors: new features identified.Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.A review on camptothecin analogs with promising cytotoxic profile.Structure-activity relationships of HDAC8 inhibitors: Non-hydroxamates as anticancer agents.Designing Potential Antitrypanosomal Thiazol-2-ethylamines through Predictive Regression Based and Classification Based QSAR Analyses.An integrated ligand-based modelling approach to explore the structure-property relationships of influenza endonuclease inhibitorsFirst report on the structural exploration and prediction of new BPTES analogs as glutaminase inhibitorsExploring structural requirements of unconventional Knoevenagel-type indole derivatives as anticancer agents through comparative QSAR modeling approachesDesigning potential HDAC3 inhibitors to improve memory and learningDiverse classes of HDAC8 inhibitors: in search of molecular fingerprints that regulate activityDesign, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effectsMonte Carlo based modelling approach for designing and predicting cytotoxicity of 2-phenylindole derivatives against breast cancer cell line MCF7Structural exploration for the refinement of anticancer matrix metalloproteinase-2 inhibitor designing approaches through robust validated multi-QSARsDiscriminations of active from inactive HDAC8 inhibitors Part II: Bayesian classification study to find molecular fingerprintsDevelopment of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioningQSAR modelling on a series of arylsulfonamide-based hydroxamates as potent MMP-2 inhibitorsExploring the structural aspects of ureido-amino acid-based APN inhibitors: a validated comparative multi-QSAR modelling studyHistone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overviewSelective and nonselective HDAC8 inhibitors: a therapeutic patent reviewGood and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR studyHDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approachesHistone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamidesExploration of good and bad structural fingerprints for inhibition of indoleamine-2,3-dioxygenase enzyme in cancer immunotherapy using Monte Carlo optimization and Bayesian classification QSAR modelingStructural exploration of tetrahydroisoquinoline derivatives as HDAC8 inhibitors through multi-QSAR modeling studyEssential elements regulating HDAC8 inhibition: a classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitorsSynthesis, anticancer activity, structure-activity relationship and binding mode of interaction studies of substituted pentanoic acids
P50
Q38670110-B56AB8E1-EE84-4359-B41E-FB522CD6DD73Q38684285-8D5EA9CC-C5D6-4BFB-B96F-B3B68BB98F3CQ45298889-0BA9F5A7-9BF8-46D8-84EE-2BD2DB720322Q45948709-FF59B9E1-2334-4597-B7A4-EF0B522C4966Q47282083-3828ADF3-F979-4D02-98D4-6B063886C83EQ47357144-C07E6018-424A-44A6-B985-F961B1547CE2Q47775396-B08D2097-CA7B-4762-8C05-204EF9923BF5Q47871160-EA206C10-307B-4A25-AB34-00D1650B95B7Q48125556-E9315715-75CF-4EB4-83C7-2F3EA7D97C81Q48285525-22A15237-402A-4E48-96E4-CF030B0F8C3BQ50152805-2875F728-EAA9-4801-8891-21A7AADF20CDQ51092695-96322337-64FC-4611-B0F8-C8FA323A6073Q51098915-CB6228B4-51C6-4ABB-9E27-31A62DBD6504Q51232040-C966FF9C-21A6-45C0-95E0-DD859744B416Q52642452-804B8871-B8F0-466A-9046-12C8A837F9EAQ52720700-26AEABCD-4019-4120-AF7E-F8E0410F685FQ52723621-71E903B2-F4C9-4D80-823C-1451887B7FC9Q52728188-E85B2AD4-5B7E-4BDA-95B2-9B574717249CQ54764964-4034F0A5-5FB2-478A-B20C-763971908C37Q56898040-A5ACDCDC-240F-4D24-B52D-A22588845153Q56898063-103CF1F9-33BA-446D-8849-315A9975D30DQ56898096-8E7CD54F-7AA8-46C8-A49E-8D7F7C6426CEQ57174743-A95FC0DB-7153-4969-8D48-81A0517BF58DQ57178118-ABB9DCE9-372F-4729-9C7E-E8EA3E845FA8Q58231161-F2FAE34F-2EA8-4387-920A-DD4D7CA2C999Q58231163-256AD801-32E1-4AD8-BAFC-6CC531FC0F0DQ58231167-D00B7D75-D27C-488E-81A6-2CBB49540536Q89775143-970757CA-F806-450F-AAA7-31BF98D9CFE7Q90146104-E812097A-666F-4F51-88D8-EDCEE5714754Q90223541-3DC7F21B-BF03-4601-818A-D3B643AEFB52Q90341443-BACA77AD-F242-4BBA-8B42-8DC4F2EB3D3AQ90807287-FD4ADE59-F994-4CB2-9D1E-64ED46C4C230Q90995884-22B7449F-035C-4FAB-B0F3-2F3A7E1EE539Q91060788-58CC5B05-1AFB-4829-96DD-7A97556E529AQ91282923-D234B0CD-0F0E-41B2-A858-F363A882BB6EQ91422527-7F56B8CE-D12E-49C3-A5B2-5A5076F15308Q91774609-25ABF942-9630-452C-AE5E-4ED375E5C22DQ91910280-056E7687-6091-4616-AD00-CD3A620FC04DQ91924101-175E9A3A-6E45-4A58-80E3-B160F581FB4BQ92347239-336679CB-4245-41E9-8941-8049E6E8D48C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sk. Abdul Amin
@ast
Sk. Abdul Amin
@en
Sk. Abdul Amin
@es
Sk. Abdul Amin
@nl
type
label
Sk. Abdul Amin
@ast
Sk. Abdul Amin
@en
Sk. Abdul Amin
@es
Sk. Abdul Amin
@nl
prefLabel
Sk. Abdul Amin
@ast
Sk. Abdul Amin
@en
Sk. Abdul Amin
@es
Sk. Abdul Amin
@nl
P106
P1153
57190176332
P31
P496
0000-0003-4799-7322